Literature DB >> 8166151

Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group.

J P Metcalf1, S I Rennard, E C Reed, W D Haire, J H Sisson, T Walter, R A Robbins.   

Abstract

BACKGROUND: Diffuse alveolar hemorrhage is a frequent complication of treating malignancies with high-dose chemotherapy and bone marrow transplantation and is associated with very high mortality. This disorder's association with pulmonary inflammation, its coincidence with marrow recovery, and the usefulness of corticosteroids for treating other pulmonary hemorrhage syndromes provided the rationale for this study.
METHODS: We retrospectively studied 65 episodes of diffuse alveolar hemorrhage that has occurred in 63 of 603 consecutively treated patients who had undergone high-dose chemotherapy with bone marrow transplantation. Patients were divided into three groups according to the therapy they had received for diffuse alveolar hemorrhage: supportive therapy alone (n = 12); low-dose corticosteroids (30 mg or less of methylprednisolone or its equivalent; n = 10); and high-dose corticosteroids (more than 30 mg methylprednisolone or its equivalent; n = 43). The primary outcome measures were overall survival and survival to hospital discharge, occurrence of respiratory failure requiring intubation, and development of infections subsequent to the diagnosis of diffuse alveolar hemorrhage.
RESULTS: Overall survival at the end of the follow-up period was significantly higher for the high-dose corticosteroid group compared with the supportive therapy group (P = 0.005); however, treatment with low-dose steroids did not increase survival over supportive therapy alone (P = 0.198). In addition, survival to discharge was significantly increased for the high-dose group compared with the other two groups combined (33% versus 9.1%, P = 0.038). Respiratory failure after the diagnosis of diffuse alveolar hemorrhage developed in only 12 of the 22 unintubated patients in the high-dose group compared with 9 of the 10 initially unintubated patients in the other two groups (P = 0.056). Although the incidence of infections was high (40%) subsequent to diffuse alveolar hemorrhage, neither high-dose nor low-dose corticosteroid treatment significantly increased the risk of infections (P > 0.4, all comparisons).
CONCLUSIONS: In this study, high-dose corticosteroid therapy for diffuse alveolar hemorrhage related to bone marrow transplantation was associated with improved total survival and survival to hospital discharge, and decreased development of respiratory failure in these patients. These results suggest the therapy is beneficial, and further prospective studies are warranted to verify the effectiveness of the treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166151     DOI: 10.1016/0002-9343(94)90062-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.

Authors:  Jason M Elinoff; Ulas Bagci; Brad Moriyama; Jennifer L Dreiling; Brent Foster; Nicole J Gormley; Rachel B Salit; Rongman Cai; Junfeng Sun; Andrea Beri; Debra J Reda; Farhad Fakhrejahani; Minoo Battiwalla; Kristin Baird; Jennifer M Cuellar-Rodriguez; Elizabeth M Kang; Stephen Z Pavletic; Dan H Fowler; A John Barrett; Jay N Lozier; David E Kleiner; Daniel J Mollura; Richard W Childs; Anthony F Suffredini
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-20       Impact factor: 5.742

Review 2.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

3.  Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage.

Authors:  N K Rathi; A R Tanner; A Dinh; W Dong; L Feng; J Ensor; S K Wallace; S A Haque; G Rondon; K J Price; U Popat; J L Nates
Journal:  Bone Marrow Transplant       Date:  2014-12-22       Impact factor: 5.483

4.  Diffuse alveolar hemorrhage after erlotinib combined with concurrent chemoradiotherapy in a patient with esophageal carcinoma.

Authors:  Chuan-Hua Zhao; Rong-Rui Liu; Li Lin; Jian-Zhi Liu; Fei-Jiao Ge; Shan-Shan Li; Chen-Yang Ye; Yu-Ling Chen; Yan Wang; Jian-Ming Xu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 5.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Authors:  Gregory A Yanik; Vincent T Ho; John E Levine; Eric S White; Thomas Braun; Joseph H Antin; Joel Whitfield; Joseph Custer; Dawn Jones; James L M Ferrara; Kenneth R Cooke
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

Review 7.  Non-infectious pulmonary complications after bone marrow transplantation.

Authors:  I Khurshid; L C Anderson
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

8.  Defective pulmonary innate immune responses post-stem cell transplantation; review and results from one model system.

Authors:  Racquel Domingo-Gonzalez; Bethany B Moore
Journal:  Front Immunol       Date:  2013-05-24       Impact factor: 7.561

9.  Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series.

Authors:  Jongmin Lee; Chin Kook Rhee; Seok Chan Kim; Young Kyoon Kim; Hee Je Kim; Seok Lee; Seok-Goo Cho; Jong Wook Lee
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

Review 10.  Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation.

Authors:  Güldane Cengiz Seval; Pervin Topçuoğlu; Taner Demirer
Journal:  Balkan Med J       Date:  2018-03-15       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.